bioMérieux Acquires Invisible Sentinel
February 7, 2019
bioMérieux has acquired Invisible Sentinel Inc., a Philadelphia-based developer of Veriflow molecular diagnostic tools for food and beverage pathogen and spoilage detection, for approximately $75 million in cash. The deal strengthens bioMérieux's food pathogen testing capabilities, complements its GENE-UP molecular food testing solution and expands its reach into new customer segments such as breweries and wineries.
- Buyers
- bioMérieux
- Targets
- Invisible Sentinel Inc.
- Industry
- Biotechnology
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Mérieux NutriSciences Acquires Bureau Veritas' Food Testing Activities in the U.S. and Canada
January 6, 2025
Environmental Services
Mérieux NutriSciences has completed the acquisition of Bureau Veritas' food testing activities in the United States and Canada, adding 12 laboratories and approximately 400 employees across the region. The deal expands Mérieux NutriSciences' North American footprint and is part of a broader, multi‑jurisdictional purchase of Bureau Veritas' global food laboratory testing business.
-
Microbiologics Acquires SensID to Expand Diagnostic Reference Materials Portfolio
November 6, 2024
Biotechnology
Microbiologics has acquired SensID, a Rostock, Germany-based maker of reference materials and quality controls for molecular diagnostics, marking Microbiologics' first location outside the United States. The deal expands Microbiologics' capabilities into oncology and precision medicine and combines both companies' expertise to broaden diagnostic quality-control offerings for diagnostic developers and clinical labs.
-
Eurofins Scientific Acquires Infinity Laboratories
September 16, 2024
Healthcare Services
Eurofins Scientific has completed the acquisition of Infinity Laboratories, a U.S.-based contract testing group that operates eight laboratories and employs approximately 100 staff. The deal expands Eurofins' microbiology and package testing footprint across the United States, enhancing its BioPharma and Medical Device testing capabilities and geographic coverage.
-
Bureau Veritas Acquires Security Innovation Inc.
July 25, 2024
Cybersecurity
Bureau Veritas has signed an agreement to acquire Security Innovation Inc., a US-based software security consulting firm headquartered in Boston. The deal adds ~95 specialists and EUR 21 million of 2023 revenue to Bureau Veritas' cybersecurity capabilities and establishes a new cybersecurity hub in the US; closing is expected in Q3 2024.
-
Sherlock Biosciences Acquires Sense Biodetection
February 1, 2023
Biotechnology
Sherlock Biosciences has acquired Sense Biodetection to accelerate commercialization of CRISPR-enabled, instrument-free molecular diagnostics by integrating Sense’s Veros rapid, instrument-free test platform, chemistry and manufacturing capabilities into Sherlock’s platform. Terms were not disclosed; Sense is headquartered in Oxford, United Kingdom with additional facilities in Cambridge (UK) and Milford, Massachusetts.
-
Merck & Co., Inc. Acquires VelosBio Inc.
November 5, 2020
Biotechnology
Merck & Co., Inc. will acquire all outstanding shares of clinical-stage biopharmaceutical company VelosBio for $2.75 billion in cash. The acquisition adds VelosBio's lead investigational antibody-drug conjugate VLS-101 and ROR1-directed pipeline assets to Merck's oncology portfolio and is expected to close by the end of 2020, subject to customary conditions.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.